These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6123362)

  • 1. Adrenergic mechanisms in control of plasma lipid concentrations.
    Lehtonen A
    Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1708. PubMed ID: 6123362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-blockers and plasma lipids].
    Soulier C; Merle L
    Therapie; 1993; 48(4):385-91. PubMed ID: 7907443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of beta-adrenoblockaders on the lipid composition of the blood].
    Veĭkin AK; Mukhin EP; Preobrazhenskiĭ DV
    Ter Arkh; 1995; 67(8):30-3. PubMed ID: 7482329
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered adrenergic control in hypercholesterolemia.
    Ohanian J; Nicolosi RJ; Vatner SF; Graham RM; Kowala MC; Young MA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S11-5. PubMed ID: 2447434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How do serum lipids behave under beta blockade?].
    Krönig B
    Med Welt; 1982 Apr; 33(17):3. PubMed ID: 6124862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-adrenergic inhibitors and atherogenic risk].
    Jacotot B; Richard JL
    Therapie; 1985; 40(6):387-91. PubMed ID: 2868532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possible effect of betablockers on parameters of lipid metabolism].
    Karoff C; Karoff M
    Med Welt; 1982 Jul; 33(26):953-4. PubMed ID: 6125871
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of alpha/beta blockers on serum lipids.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):228-30. PubMed ID: 6114045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A; Tanskanen A; Temmerman J
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL
    Wien Med Wochenschr; 1982; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise.
    Peden NR; Dow RJ; Isles TE; Martin BT
    Br Med J (Clin Res Ed); 1984 Jun; 288(6433):1788-90. PubMed ID: 6145480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of reserpine as well as alpha- and beta receptor blockaders on the lipid metabolism following endotoxin].
    Schmahl FW; Ohlemutz A; Huth K
    Verh Dtsch Ges Inn Med; 1969; 75():900-3. PubMed ID: 4396077
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of beta adrenoceptor blockade.
    Kendall MJ; Smith SR
    Arq Bras Cardiol; 1984 Sep; 43(3):201-7. PubMed ID: 6152577
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
    Leonhardt U; Nürnberger H; Femmer K
    Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in plasma lipids consequent to endurance training and beta-blockade.
    Morton AR; Stanforth PR; Freund BJ; Joyner MJ; Jilka SM; Hartzell AA; Ewy GA; Wilmore JH
    Med Sci Sports Exerc; 1989 Jun; 21(3):288-92. PubMed ID: 2567483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-2-adrenergic receptor polymorphisms and changes in lipids induced by metoprolol.
    Isaza CA; Henao J; Sánchez JC; Porras GL; Cardona J; Bedoya G
    Pharmacology; 2007; 80(4):279-85. PubMed ID: 17671401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM
    Circulation; 1990 Sep; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes during antihypertensive therapies.
    Krone W; Nägele H
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.